6 months ago, M.N., 38, was diagnosed with an extremely rare and aggressive type of cancer. A cancer that progresses tremendously rapidly in the body, very deadly. Out of the well-known and standard drugs, none can really help her.
We immediately put the case into work to identify clinical trials, compassionate medications, case studies in the literature and did a comprehensive literature review to find her the drug that might give her a chance, far beyond any other standard treatment with the obvious drugs.
We identified the drug
We found a very limited number of drugs specific to M.N. One is a new drug and is still in research, which means it is not yet approved for use and treatment of cancer patients and can be accepted on the condition that you enter the study.
Her treating oncologist also recommended this drug from the options we presented to her and the family, and thought it was the drug that M.N. should get more than any other treatment.
But … the clinical trial is not open in Israel and we must get this ‘winner’!
“Compassionate Treatment” –
The only way to get the drug is as a “compassionate drug” – see below for an explanation of “compassionate drug” – we entered the process directly with the headquarters of the pharmaceutical company in England and the US, the medical center where the patient is treated, the oncologist, the pharmacy, facing the procurement, the approval committee at the medical center, the customs and the import of medicines and other professional bodies …
And we don’t have time, it’s a galloping illness, but we managed to get the drug company’s consent to give the drug as compassion and send it to us at her expense!
At the beginning of the week the drug landed in Israel and arrived at the pharmacy at the medical center.
M.N. will start receiving the drug and we only wish for one thing – that she responds to the treatment, that the drug will stop the cancer from growing, shrink it and that it will last for as long as possible.
This is how we fight for life!
This is our power and we are at your service
Do not give up on life!
Contact us 24/7:
What are Compassionate Treatments and to whom do they suit?
Compassionate treatment or compassionate use drug is a medical treatment administered to a patient who suffers a life-threatening disease or a disease-causing severe disability.
A patient who cannot be properly be treated with a registered and approved treatments or be in the scope of a clinical trials.
Contrary to the common belief, compassionate treatment or drug are designated for cancer patients at any staging of the disease, when all other treatment and therapies have been exhausted and they are in terminal condition.
These are some of the most advanced treatments existing in the world and it is important to know about them in the same way we know about any other treatment.
Who develops these treatments?
Compassionate treatments is usually developed by a pharmaceutical or medical device companies.
Compassionate use is usually a drug developed by a company which agrees to provide it to the patient outside of the study scope, and prior to its final approval by the health authorities worldwide.
As long as the treatment or the drug are unapproved by the health authorities worldwide, they may be distributed free of charge.
There is no obligating a pharmaceutical company to agree to any application for compassionate use, however, when they do agree, the patient might gain from the compassion demonstrated by the company towards him or her.
What are the goals of Compassionate drugs?
The goal is to improve the patient’s medical condition and help the patient in his or her fight against cancer.
We equip the patient with personalized medical information, in a clear and concise format, with which the patient may continue to consult his or her attending physician in order to make a treatment decision together.
TRIAL-IN Pharma has a unique expertise that combines the identification and analysis of compassionate treatments at various stages of development and facilitates the accessibility to treatments and clinical trials from around the world.